Menorease
Sources
Menorease
Clinical Summary
Menorease is an Indian herbal/nutraceutical supplement marketed for menopausal symptom management.
Documented on November 2022 medication list as "1 tab once daily, morning (ongoing)." Strength not specified.
Status: Discontinued. Not present on the May 2026 handwritten prescription. Discontinued at unknown date between November 2022 and May 2026.
Dosing History
| Date | Dose | Frequency | Route | Context | Status |
|---|---|---|---|---|---|
| 2022-11-25 | Unknown | Once daily (morning) | Oral | Nov 2022 medication list — "ongoing" | Active |
| Unknown (between 2022–2026) | — | — | — | Not on 2026 Rx | Discontinued |
Clinical Context
Menorease is typically formulated with a combination of:
- Soy isoflavones
- Cimicifuga (black cohosh)
- Vitamin E
- Other herbal/nutraceutical components
Prescribed as ongoing supplementation, presumably for post-menopausal symptom management. At 81 years of age in 2026, Ishamma has long been post-menopausal.
[!info] Discontinued Before AML Diagnosis
Menorease was listed on the November 2022 medication list but is absent from the May 2026 prescription. The exact date of discontinuation is unknown. No adverse effects or clinical rationale for discontinuation documented.
Related
- Vitamin E — Vitamin E (Evitol) was also separately prescribed in 2022; also discontinued
Medication page created 2026-05-06 from Nov 2022 historical medication list (raw/clinic-notes/2026-05-06_note.md). Discontinued at unknown date before 2026-05-04.